Description générale
INN
Octreotide
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 2023
(TRS
1049)
pour
Acromegaly or pituitary gigantism
Wikipédia
DrugBank
Recommandations
Section
Medicines for disorders of the pituitary hormone system
- Parenteral > General injections > IM: 20 mg in vial (modified-release, as acetate) plus diluent
- Parenteral > General injections > SC: 0.05 mg per mL in 1 mL vial (immediate-release, as acetate); 0.1 mg per mL in 1 mL vial (immediate-release, as acetate); 0.5 mg per mL in 1 mL vial (immediate-release, as acetate)
Indications